Tenet Healthcare Co. (NYSE:THC - Free Report) - Stock analysts at Zacks Research decreased their Q1 2026 earnings per share (EPS) estimates for shares of Tenet Healthcare in a note issued to investors on Wednesday, March 26th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $3.43 per share for the quarter, down from their prior forecast of $3.45. The consensus estimate for Tenet Healthcare's current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare's Q4 2026 earnings at $3.56 EPS and FY2026 earnings at $13.40 EPS.
Several other equities research analysts have also recently issued reports on THC. StockNews.com upgraded shares of Tenet Healthcare from a "hold" rating to a "buy" rating in a research report on Thursday, March 13th. JPMorgan Chase & Co. reissued an "overweight" rating and set a $175.00 price objective on shares of Tenet Healthcare in a report on Tuesday, December 17th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $177.00 target price on shares of Tenet Healthcare in a report on Thursday, February 13th. The Goldman Sachs Group lowered Tenet Healthcare from a "buy" rating to a "neutral" rating and dropped their price target for the company from $196.00 to $140.00 in a research note on Monday, December 16th. Finally, Truist Financial decreased their price objective on Tenet Healthcare from $190.00 to $175.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Three analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, Tenet Healthcare currently has a consensus rating of "Moderate Buy" and a consensus price target of $166.41.
View Our Latest Report on Tenet Healthcare
Tenet Healthcare Price Performance
Shares of NYSE:THC traded up $0.49 during trading on Friday, hitting $134.99. 295,852 shares of the company's stock were exchanged, compared to its average volume of 1,479,540. The business's 50-day simple moving average is $132.51 and its 200 day simple moving average is $142.15. The company has a debt-to-equity ratio of 2.25, a current ratio of 1.78 and a quick ratio of 1.70. Tenet Healthcare has a 52-week low of $90.03 and a 52-week high of $171.20. The company has a market cap of $12.84 billion, a price-to-earnings ratio of 4.19, a PEG ratio of 1.02 and a beta of 2.06.
Tenet Healthcare (NYSE:THC - Get Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%.
Insider Buying and Selling at Tenet Healthcare
In other Tenet Healthcare news, Director J Robert Kerrey sold 9,525 shares of the company's stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total value of $1,194,720.75. Following the completion of the sale, the director now directly owns 27,378 shares in the company, valued at approximately $3,434,022.54. This represents a 25.81 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.93% of the stock is owned by corporate insiders.
Institutional Trading of Tenet Healthcare
Institutional investors and hedge funds have recently made changes to their positions in the company. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Tenet Healthcare by 10.3% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 8,836 shares of the company's stock valued at $1,115,000 after purchasing an additional 827 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Tenet Healthcare during the fourth quarter worth $8,783,000. Forum Financial Management LP boosted its position in Tenet Healthcare by 43.5% during the 4th quarter. Forum Financial Management LP now owns 2,469 shares of the company's stock valued at $312,000 after acquiring an additional 749 shares in the last quarter. Neo Ivy Capital Management bought a new position in shares of Tenet Healthcare in the 4th quarter worth $2,773,000. Finally, Vise Technologies Inc. lifted its stake in shares of Tenet Healthcare by 28.4% during the 4th quarter. Vise Technologies Inc. now owns 1,613 shares of the company's stock worth $204,000 after purchasing an additional 357 shares during the last quarter. 95.44% of the stock is currently owned by institutional investors.
Tenet Healthcare Company Profile
(
Get Free Report)
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Further Reading
Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
